超早期脑梗死应用阿替普酶静脉溶栓联合口服丁苯酞治疗的临床观察

Clinical Observation of Arteplase Intravenous Thrombolysis Combined with Oral Butylphthalide in the Treatment of Ultra-early Cerebral Infarction

目的分析超早期脑梗死应用阿替普酶静脉溶栓联合口服丁苯酞治疗的临床效果。方法选择2017年4月至2019年4月在我院治疗的120例超早期脑梗死患者。所有患者进行随机分组,观察组60例运用阿替普酶静脉溶栓联合口服丁苯酞治疗,对照组60例运用阿替普酶静脉溶栓治疗,两组通过神经功能受损进行对比。结果两组通过神经功能受损对比,观察组治疗后的1个月、2个月均好于对照组(P<0.05)。结论对超早期脑梗死患者运用阿替普酶静脉溶栓联合口服丁苯酞治疗,有效改善患者神经功能,使其快速恢复,对于临床治疗具有重要的作用。

Objective To analyze the clinical effect of intravenous thrombolysis with ateplase combined with oral butylphthalide in the treatment of ultraearly cerebral infarction.Methods 120 patients with super-early cerebral infarction treated in our hospital from April 2017 to April 2019 were selected.All patients were randomly divided into two groups.60 patients in the observation group were treated with intravenous thrombolysis of ateplase combined with oral butylphthalide,and 60 patients in the control group were treated with intravenous thrombolysis of ateplase.The neurological impairment was compared between the two groups.Result By comparing the neurological impairment between the two groups,the observation group was better than the control group in 1 and 2 months after treatment(P<0.05).Conclusion Atyplase intravenous thrombolysis combined with oral butylphthalide can effectively improve the neurological function of patients with super-early cerebral infarction and make them recover quickly.It has an important role in clinical treatment.